United Asset Strategies’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,575
Closed -$12.3K 249
2024
Q1
$12.3K Sell
17,575
-131
-0.7% -$148 ﹤0.01% 233
2023
Q4
$31K Buy
17,706
+7,700
+77% +$11.2K ﹤0.01% 231
2023
Q3
$14.4K Hold
10,006
﹤0.01% 227
2023
Q2
$26K Sell
10,006
-215
-2% -$643 ﹤0.01% 226
2023
Q1
$37.6K Sell
10,221
-3,000
-23% -$12.6K 0.01% 219
2022
Q4
$23.4K Hold
13,221
﹤0.01% 222
2022
Q3
$52K Hold
13,221
0.01% 200
2022
Q2
$73K Sell
13,221
-300
-2% -$2.46K 0.01% 200
2022
Q1
$198K Hold
13,521
0.03% 201
2021
Q4
$214K Buy
13,521
+300
+2% +$7.21K 0.03% 193
2021
Q3
$425K Hold
13,221
0.05% 155
2021
Q2
$550K Buy
13,221
+5,686
+75% +$234K 0.07% 141
2021
Q1
$383K Sell
7,535
-925
-11% -$48.4K 0.06% 161
2020
Q4
$274K Buy
+8,460
New +$120K 0.04% 180

Other funds holding DMTK

United Asset Strategies's DMTK Position: Q2 2024 in Review

United Asset Strategies sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 17,575 shares — an estimated $12.3K sold.

United Asset Strategies first reported a position in DMTK in Q4 2020 and held it in 14 quarters. The position peaked at $550K in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • United Asset Strategies reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • United Asset Strategies sold 17,575 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $12.3K.
  • United Asset Strategies first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • United Asset Strategies's DermTech, Inc. Common Stock position peaked at $550K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on United Asset Strategies's 13F filing for Q2 2024, filed 1 Aug 2024.